Sign In
Buy ABBV
$224.93
+7.86 (+3.62%)
At Close: Jun 04, 2026
Will These 5 Medical Stocks Surpass Q2 Earnings Forecasts?
12:15pm, Tuesday, 23'rd Jul 2024
Let's look at five biotech and drug companies, AZN, ABBV, VKTX, SNY and BMY, slated to release their second-quarter 2024 results this week.
BOSTON and SOUTH SAN FRANCISCO, Calif., July 23, 2024 (GLOBE NEWSWIRE) -- Frontier Medicines Corporation (“Frontier” or the “Company”), a clinical-stage precision medicine company seeking to u
AbbVie (ABBV) Stock Before Q2 Earnings: To Buy or Not to Buy?
10:51am, Monday, 22'nd Jul 2024
Investor focus will likely be on sales of AbbVie's (ABBV) blockbuster immunology drugs Rinvoq and Skyrizi when it reports second-quarter results.
AbbVie Could Soar 24%, According to a Wall Street Analyst. Is the High-Yield Dividend Stock a Buy Now?
10:41am, Monday, 22'nd Jul 2024
AbbVie's lead drug, Humira, lost patent-protected market exclusivity in 2023, but sales have been relatively resilient to new competition. Despite losing billions in Humira revenue, total sales are st
10 Best Dividend Growth Stocks to Buy and Hold Forever
10:30am, Sunday, 21'st Jul 2024
These blue-chip companies have demonstrated strong dividend growth rates ranging from 7.69% to 15.8% annually over the past five years. The list includes diverse sectors such as retail, healthcare, te
7 Investments To Buy And Hold For Next 10 Years
09:00am, Saturday, 20'th Jul 2024
We present a diversified yet simple portfolio of 6 stocks and one ETF with nearly 4% dividend yield. The portfolio has been designed for retirees and income investors whose needs are generally met wit
AbbVie (ABBV) Rises As Market Takes a Dip: Key Facts
06:51pm, Friday, 19'th Jul 2024
AbbVie (ABBV) closed at $172.32 in the latest trading session, marking a +0.69% move from the prior day.
AbbVie: Why I Sold My Shares At $175
02:36pm, Friday, 19'th Jul 2024
We recently sold our ABBV shares at $175. The stock has reached our target valuation at this price. More fundamentally, we think the market has corrected its overreaction to the Humira patent cliff by
Earnings Preview: AbbVie (ABBV) Q2 Earnings Expected to Decline
11:07am, Thursday, 18'th Jul 2024
AbbVie (ABBV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
AbbVie Q2 2024 Earnings Preview: Post Gonzalez Era Can Begin On Positive Note
02:43pm, Wednesday, 17'th Jul 2024
AbbVie Inc. will announce its Q2 2024 earnings next Thursday, 25th July. The company has a new CEO, with insider Rob Michael taking the reins after long-term CEO Rick Gonzalez's retirement. Wall Stree
7 High-Yield Dividend Stocks to Help Pay Your Bills
02:18pm, Wednesday, 17'th Jul 2024
While active acquisition is perhaps the most common methodology of gaining wealth, it's not always the most efficient. For example, even if you trade your hours for a generous paycheck, there are only
3 Absurdly Cheap Stocks to Buy and Hold for Years
08:25am, Wednesday, 17'th Jul 2024
Drugmaker AbbVie has been investing in its growth, and that strategy looks to be paying off. Verizon's stable business and low valuation make it practically a no-brainer buy for dividend investors.
7 High-Yield Dividend Stocks Beating Inflation
02:00pm, Tuesday, 16'th Jul 2024
At this writing, current inflation rate is 3% over the past 12 months. That's the reading as of the end of June.
Trade Tracker: Rob Sechan sells Bristol Myers and buys more Abbvie
01:27pm, Tuesday, 16'th Jul 2024
Rob Sechan, CEO of NewEdge Wealth, joins CNBC's "Halftime Report" to discuss his latest moves. The Committee discuss the Healthcare sector.
7 Recession-Proof Stocks to Shield Your Portfolio in 2024
06:00am, Tuesday, 16'th Jul 2024
U.S. News & World Report recently said the New York Fed's Recession Probability model hints that within the next 12 months, we stand a 55.8% chance of a recession. One can never be too safe though.
